Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Dova Pharmaceuticals, Inc. (DOVA)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-18Dec-31-17
   10-K10-K
Net income  -72.3-30.0
Depreciation and amortization   [+]0.0 
Stock-based compensation  12.55.6
Change in working capital   [+]3.01.9
Other operating activities  3.111.5
Cash from operations  -53.7-10.9
   
Capital expenditures  -0.4-0.1
Other cash from investing   -1.0
Cash from investing  -0.4-1.1
   
Issuance of common stock, net  80.086.3
Option exercises  0.10.1
Financing costs  0.0 
Other cash from financing  -16.1-8.1
Cash from financing  63.878.1
   
Free cash flow  -54.0-11.0
        Per share (diluted)  ($1.94)($0.51)
   
Cash paid for interest  2.20.4

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy